4^th International Conference on Rare Diseases and Orphan Drugs

AI in Rare Diseases and Orphan Drugs: Artificial Intelligence (AI) in rare diseases and orphan drugs refers to the use of advanced computational methods to identify disease patterns, predict treatment response, accelerate drug discovery, and support clinical decision-making. AI helps overcome limited patient data, enabling faster diagnosis and more targeted therapeutic development.

Submit Abstract

Related Tags:

1. Rare Diseases and Orphan Expos
2. Orphan Drugs Summit
3. Orphan Drugs Expos
4. Rare Diseases Exhibitions